Cipla Ltd. — Regulatory Filings 2023

Apr 25, 2023

==> picture [84 x 30] intentionally omitted <==

25[th] April 2023

(1) BSE Limited (2) National Stock Exchange of India Limited Listing Department, Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Scrip Code: 500087 Scrip Code: CIPLA EQ

• (3) SOCIETE DE LA BOURSE DE LUXEMBOURG

Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Dear Sir/Madam,

- Sub: Dissolution of wholly owned step down subsidiary

This is to inform you that Madison Pharmaceuticals Inc. (“Madison”), wholly owned step-down subsidiary of the Company in Delaware, USA, will be dissolved with effect from 28[th] April 2023. Madison is a dormant entity, and this dissolution will not affect the performance or revenue of the Company.

This is for your information and records.

Thanking you

Yours faithfully,

For Cipla Limited

RAJEND Digitally signed RA by RAJENDRA KUMAR CHOPRA KUMAR Date: 2023.04.25 18:10:11 +05'30' CHOPRA

Rajendra Chopra Company Secretary

Prepared by: Simona Dsouza

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India P +91 22 24826000 F +91 22 24826120 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Numbe r L24239MH1935PLC002380